New approaches are needed for predicting the safe dose of novel drugs that are designed to interact with highly specific human targets because existing preclinical toxicology studies may be inadequate.
The IP battlefield is large and diversified. It goes way beyond highly-publicized battles about patenting genes or semi-conductor designs. A case in point is a lawsuit filed July 14 by Materialise nv, a spin-off of Belgium’s Katholieke Universiteit Leuven, against a Swiss-Swedish company, Nobel Biocare.
You have until the end of the month to tell the EU about your "needs in relation to transnational research cooperation and knowledge transfer between public research organisations".
The European Union’s €54 billion research budget for the next seven years may not be approved in time for the beginning of next year – if Slovenia carries out its threat to oppose the funding of stem cell research.
The technology-transfer unit of Imperial College London, continuing preparations for its stock-market debut on 31 July, said it has completed a £25 million private placement and set a public share price that would value the business at £181 million.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.